Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Aspiration pneumonitis and aspiration pneumonia

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Witnessed large-volume aspiration with hypoxaemia, bronchospasm, airway obstruction, shock or reduced consciousness requires immediate airway and critical-care assessment. Suction visible material, support oxygenation and ventilation, but do not perform blind airway sweeps or give automatic antibiotics for chemical pneumonitis.

Synopsis

Separate sterile chemical aspiration pneumonitis from bacterial aspiration pneumonia, stabilise acute lung injury, treat infection proportionately, and reduce recurrence through swallowing, oral-care and person-centred feeding decisions.

  • Aspiration pneumonitis is an acute chemical injury, often after witnessed large-volume gastric aspiration in a person with reduced consciousness; aspiration pneumonia is infection after aspiration of bacteria-rich secretions.
  • The distinction is temporal and clinical, not established by procalcitonin: pneumonitis can improve over 24–48 hours with support, whereas persistent or later fever and deterioration suggest secondary infection.
  • Assess swallowing impairment, consciousness, neurological disease, frailty, reflux, dentition, sedative medicines, feeding dependence and the patient's baseline communication and goals.
  • Chest radiography can miss aspiration pneumonia; CT is appropriate when the film is inconclusive and the diagnosis or a complication remains important.
  • Do not give prophylactic antibiotics after uncomplicated chemical aspiration. Treat established aspiration pneumonia using local microbiology guidance; co-amoxiclav is a reasonable common initial choice.
  • Routine extra anaerobic cover is not recommended; include it when putrid sputum, severe dental disease, lung abscess or empyema makes anaerobic infection credible.
  • BTS suggests five total days when aspiration pneumonia is improving clinically, with IV-to-oral switch only when swallowing and absorption are safe.
  • Prevent recurrence with speech and language therapy assessment, twice-daily tooth/tongue/palate brushing, medication review, positioning and individualised feeding decisions; tubes do not eliminate aspiration.

Key red flags

Chemical pneumonitis

Abrupt cough, wheeze, hypoxaemia and bilateral or dependent infiltrates within hours of a witnessed large gastric aspiration, usually during reduced consciousness, anaesthesia or vomiting.

Airway obstruction or severe lung injury

Stridor, unilateral absent air entry, visible particulate material, escalating oxygen need, shock or reduced consciousness requires immediate airway and critical-care help.

Complicated infection

Putrid sputum, persistent sepsis, cavitation or pleural fluid suggests anaerobic infection, lung abscess or empyema and changes both duration and source control.

Investigation priorities

01
Witness and swallowing historyFirst step

Distinguish abrupt chemical aspiration from infective microaspiration and identify recurrence risks.

Management branches

ImmediateManage witnessed macroaspiration

Abrupt respiratory deterioration during vomiting, feeding, anaesthesia or reduced consciousness.

  1. Call for airway help, position safely, suction visible oral or tracheal material, provide target-based oxygen and support ventilation; bronchoscopy is considered for persistent large particulate obstruction, not routine lavage.
  2. Assess severity with observations and gas exchange, obtain imaging when stable, and treat bronchospasm or shock through the appropriate acute pathway.
  3. Withhold prophylactic antibiotics when the presentation is uncomplicated chemical pneumonitis; reassess closely over 24–48 hours for improvement or emerging bacterial infection.

Key medicines

Co-amoxiclav for aspiration pneumoniaA typical community oral regimen is 500/125 mg three times daily for 5 days; use the locally approved IV regimen when severe or swallowing is unsafe.Do not prescribe for isolated chemical pneumonitis. Check penicillin allergy, renal function and hepatic history, then narrow from cultures and extend only for documented complication.
Alternative in immediate penicillin allergySelect a fluoroquinolone, macrolide, tetracycline or other local alternative at its current BNF dose after microbiology and patient-specific review.Fluoroquinolones have disabling adverse-effect warnings, QT and interaction risks; doxycycline is unsuitable in pregnancy. Add metronidazole only if anaerobic risk is high and the chosen agent lacks activity.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BTS Clinical Statement on aspiration pneumoniaDiagnosis, prevention, antibiotic duration and anaerobic-cover principles.
  • BTS aspiration pneumonia resource pageCurrent validity and supporting materials.
  • NICE NG250: Pneumonia diagnosis and managementCurrent national pneumonia assessment and antimicrobial framework.
  • BNF: Respiratory system infections antibacterial therapyCurrent prescribing doses and patient-specific modifiers.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom